Indeed, MM patients present both a decrease in CD19+ B cells [62,63], inversely correlated with disease stage [63], and a reduced ability to secrete polyclonal immunoglobulins and to differentiate into antibody-secreting plasma cells [62]. The gene discussed is CD19; the disease is Miyoshi myopathy.